| Report Title | Price | Action |
|---|---|---|
| P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021 Summary P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021
Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Barth Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Voltage Dependent Calcium Channel - Drugs in Development, 2021
Voltage Dependent Calcium Channel - Drugs in Development, 2021 Summary Voltage Dependent Calcium Channel - Drugs in Development, 2021 provides in de...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cells Expressing B Lymphocyte Antigen CD20 (B Lymphocyte Surface Antigen B1 or Bp35 or Leukocyte Surface Antigen Leu 16 or Membrane Spanning 4 Domains Subfamily A Member 1 or CD20 or MS4A1) - Drugs in Development, 2021
Cells Expressing B Lymphocyte Antigen CD20 (B Lymphocyte Surface Antigen B1 or Bp35 or Leukocyte Surface Antigen Leu 16 or Membrane Spanning 4 Domains...
Published: Apr-2021 | No. of Pages: 210
|
$ 3500 | |
| Galactocerebrosidase (Galactosylceramidase or Galcerase or Galactocerebroside Beta Galactosidase or Galactosylceramide Beta Galactosidase or GALC or EC 3.2.1.46) - Drugs in Development, 2021
Galactocerebrosidase (Galactosylceramidase or Galcerase or Galactocerebroside Beta Galactosidase or Galactosylceramide Beta Galactosidase or GALC or E...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B)...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021
Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 Summary Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Voltage Dependent Calcium Channel Subunit Alpha2/Delta2 (CACNA2D2) - Drugs in Development, 2021
Voltage Dependent Calcium Channel Subunit Alpha2/Delta2 (CACNA2D2) - Drugs in Development, 2021 Summary Voltage Dependent Calcium Channel Subunit Al...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021
Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021 Summary Vascular Endothelial Growth Factor...
Published: Apr-2021 | No. of Pages: 210
|
$ 3500 | |
| Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) - Drugs in Development, 2021
Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) - Drugs in Development, 2021 Summary Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) - Drugs in ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Human Papillomavirus Protein E6 (E6) - Drugs in Development, 2021
Human Papillomavirus Protein E6 (E6) - Drugs in Development, 2021 Summary Human Papillomavirus Protein E6 (E6) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 75
|
$ 3000 | |
| Hyperargininemia (Arginase I Deficiency) (Genetic Disorders) - Drugs in Development, 2021
Hyperargininemia (Arginase I Deficiency) (Genetic Disorders) - Drugs in Development, 2021 Summary Hyperargininemia (Arginase I Deficiency) (Genetic ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| 3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2 (5 Alpha SR2 or Steroid 5 Alpha Reductase 2 or Type II 5 Alpha Reductase or SR Type 2 or SRD5A2 or EC 1.3.1.22) - Drugs in Development, 2021
3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2 (5 Alpha SR2 or Steroid 5 Alpha Reductase 2 or Type II 5 Alpha Reductase or SR Type 2 or SRD5A2 or EC 1.3.1.22...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) - Drugs in Development, 2021
Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) - Drugs in Development, 2021 Summary Glucocorticoid Receptor ...
Published: Apr-2021 | No. of Pages: 220
|
$ 3500 | |
| Glycoprotein 140 (gp140) - Drugs in Development, 2021
Glycoprotein 140 (gp140) - Drugs in Development, 2021 Summary Glycoprotein 140 (gp140) - Drugs in Development, 2021 provides in depth analysis on Gl...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021
Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 Summary Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 90
|
$ 3000 | |
| Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) (Genetic Disorders) - Drugs in Development, 2021
Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) (Genetic Disorders) - Drugs in Development, 2021 Su...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021
Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021 Summary Alpha 1B Adrenergic Receptor (Alpha 1B Adrenor...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Receptor Tyrosine Protein Kinase ERBB 2 (Metastatic Lymph Node Gene 19 Protein or Proto Oncogene Neu or Proto Oncogene C ErbB 2 or Tyrosine Kinase Type Cell Surface Receptor HER2 or p185erbB2 or HER2 or CD340 or ERBB2 or EC 2.7.10.1) - Drugs in Development, 2021
Receptor Tyrosine Protein Kinase ERBB 2 (Metastatic Lymph Node Gene 19 Protein or Proto Oncogene Neu or Proto Oncogene C ErbB 2 or Tyrosine Kinase Typ...
Published: Apr-2021 | No. of Pages: 220
|
$ 3500 | |
| Growth/Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) - Drugs in Development, 2021
Growth/Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prosta...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 |